Communication
The aim of the protection of market competition is primarily to create benefits for consumers and equal conditions for all entrepreneurs on the market, who, acting in accordance with the existing rules and competing on the market with the quality, price and innovation of their products and services, contribute to the overall development of the economy.
HT/Optima conditionally approved concentration ceases 10 July 2021
With respect to the provisions under the Capital Market Act, OG 65/18 and 17/20, relating to making the inside information public and the Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, the Croatian Competition Agency (CCA) informs the public that it accepted the Extraordinary Trustee Report made by Deloitte d.o.o. from Zagreb on the activities carried out with the purpose of selling the shares of OT – Optima Telekom d.d. from Zagreb and the cessation of the concentration and thereby the management of HT-Hrvatski telekom d.d. from Zagreb over Optima as of 10 July 2021.
Namely, on 9 July 2021 Zagrebačka banka d.d. with its seat in Zagreb and Telemach Hrvatska d.o.o. with its seat in Zagreb signed the agreement on the purchase of Optima shares the implementation of which is subject to regulatory clearance and other conditions under the agreement concerned.
Regardless of the above, the agreement between HT and Zagrebačka banka on the management of Optima lapsed on 10 July 2021, which means that the management of HT over Optima ceased and as of that date HT has no management rights over Optima in line with the order of the CCA in its decision of June 2017. HT and Optima made this information public on the official site of Zagreb Stock Exchange.
In other words, and notwithstanding of the transaction concerned, in line with the CCA decision from June 2017 the concentration between HT and Optima and the management of Optima by HT ceased on 10 July 2021.
The CCA will seek a final trustee report about the measures taken regarding the conditionally approved concentration between HT and Optima that had been listed in the decision of the CCA of June 2017 and will inform the public thereof.